Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 November 2020 | Story Thabo Kessah | Photo Thabo Kessah
Prof Geofrey Mukwada says funding from the US Embassy and Consulates in South Africa will reinforce the ARU mandate.

The University of the Free State (UFS) will further strengthen its ties with the Appalachian State University in the next two academic years through a mountain-to-mountain research project funded by the US Embassy and Consulates in South Africa.

The R8 million project between the UFS and the US institution will cover the two master’s degree programmes in underdeveloped niche areas, meteorological weather stations, leadership capacity building for black women in academia, and doctoral research projects. Qwaqwa Campus departments that will be involved are Physics, Geography, Community Development, and the ARU.

Talking about this collaboration, the project leader, Prof Geofrey Mukwada, said it would bring together researchers from both the UFS and Appalachian State University and enable them to work together to develop what is currently an underdeveloped research niche, i.e. mountain studies. 

“This project will reinforce the mandate of the Afromontane Research Unit (ARU). It will provide the basis for a long-term development agenda through training and infrastructure development. For instance, the project will fund the implementation of two master’s degree programmes – the MSc in Mountain Environments and the MA in Community Development – which are long-term projects,” he said. 

“It will also support innovation in climate change research. Through this project, it will be possible to receive climate data from weather stations that are situated in distant, isolated, and generally inaccessible locations without travelling to those locations. We will be able to understand how the climate of the region is changing and assist in developing adaptation measures and decisions that are applicable to agriculture, water, tourism, environment, and other sectors. This will enhance the capacity of the ARU to contribute to the development of research in mountain environments,” he added. 

There will be a virtual launch of the project on Tuesday 10 November 2020 at 15:00 (CAT).

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept